Daiwa Securities Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-331
| Closed | -$1K | – | 1328 |
|
|
2024
Q4 | $1K | Hold |
331
| – | – | ﹤0.01% | 1278 |
|
|
2024
Q3 | $2K | Hold |
331
| – | – | ﹤0.01% | 1239 |
|
|
2024
Q2 | $1K | Hold |
331
| – | – | ﹤0.01% | 1303 |
|
|
2024
Q1 | $2K | Hold |
331
| – | – | ﹤0.01% | 1276 |
|
|
2023
Q4 | $3K | Hold |
331
| – | – | ﹤0.01% | 1250 |
|
|
2023
Q3 | $4K | Hold |
331
| – | – | ﹤0.01% | 1180 |
|
|
2023
Q2 | $8K | Hold |
331
| – | – | ﹤0.01% | 1143 |
|
|
2023
Q1 | $11K | Hold |
331
| – | – | ﹤0.01% | 1099 |
|
|
2022
Q4 | $6K | Buy |
331
+85
| +35% | +$1.54K | ﹤0.01% | 1143 |
|
|
2022
Q3 | $7K | Hold |
246
| – | – | ﹤0.01% | 1143 |
|
|
2022
Q2 | $3K | Hold |
246
| – | – | ﹤0.01% | 1201 |
|
|
2022
Q1 | $5K | Hold |
246
| – | – | ﹤0.01% | 1175 |
|
|
2021
Q4 | $4K | Hold |
246
| – | – | ﹤0.01% | 1224 |
|
|
2021
Q3 | $7K | Buy |
246
+105
| +74% | +$2.99K | ﹤0.01% | 1157 |
|
|
2021
Q2 | $4K | Hold |
141
| – | – | ﹤0.01% | 1092 |
|
|
2021
Q1 | $4K | Buy |
141
+16
| +13% | +$454 | ﹤0.01% | 1093 |
|
|
2020
Q4 | $4K | Sell |
125
-192
| -61% | -$6.14K | ﹤0.01% | 1073 |
|
|
2020
Q3 | $8K | Hold |
317
| – | – | ﹤0.01% | 1051 |
|
|
2020
Q2 | $5K | Hold |
317
| – | – | ﹤0.01% | 1093 |
|
|
2020
Q1 | $5K | Buy |
317
+37
| +13% | +$584 | ﹤0.01% | 1093 |
|
|
2019
Q4 | $5K | Hold |
280
| – | – | ﹤0.01% | 1099 |
|
|
2019
Q3 | $4K | Hold |
280
| – | – | ﹤0.01% | 1085 |
|
|
2019
Q2 | $4K | Hold |
280
| – | – | ﹤0.01% | 1103 |
|
|
2019
Q1 | $4K | Buy |
280
+78
| +39% | +$1.11K | ﹤0.01% | 1084 |
|
|
2018
Q4 | $4K | Hold |
202
| – | – | ﹤0.01% | 1064 |
|
|
2018
Q3 | $5K | Hold |
202
| – | – | ﹤0.01% | 1068 |
|
|
2018
Q2 | $6K | Hold |
202
| – | – | ﹤0.01% | 1076 |
|
|
2018
Q1 | $6K | Buy |
+202
| New | +$6K | ﹤0.01% | 1056 |
|